Quentis Therapeutics

OverviewSuggest Edit

Quentis Therapeutics develops immunotherapies targeting the endoplasmic reticulum stress response to awaken the immune system’s ability to fight cancer. The Company is at the forefront of the next generation of immuno-oncology companies that are translating novel biology into therapeutic approaches.

TypePrivate
Founded2016
HQNew York, US
Websitequentistx.com

Locations

Quentis Therapeutics is headquartered in
New York, United States

Location Map

Latest Updates

Employees (est.) (Apr 2020)6(-40%)
Cybersecurity ratingAMore

Quentis Therapeutics Office Locations

Quentis Therapeutics has an office in New York
New York, US (HQ)
430 E 29th St #1005
Show all (1)

Quentis Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Quentis Therapeutics total Funding

$48 m

Quentis Therapeutics latest funding size

$48 m

Time since last funding

3 years ago

Quentis Therapeutics investors

Quentis Therapeutics's latest funding round in February 2018 was reported to be $48 m. In total, Quentis Therapeutics has raised $48 m
Show all financial metrics

Quentis Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Quentis Therapeutics Online and Social Media Presence

Embed Graph

Quentis Therapeutics Blogs

Quentis Therapeutics Frequently Asked Questions

  • When was Quentis Therapeutics founded?

    Quentis Therapeutics was founded in 2016.

  • How many employees does Quentis Therapeutics have?

    Quentis Therapeutics has 6 employees.

  • Who are Quentis Therapeutics competitors?

    Competitors of Quentis Therapeutics include TCR CURE Biopharma, Dualogics and Tmunity Therapeutics.

  • Where is Quentis Therapeutics headquarters?

    Quentis Therapeutics headquarters is located at 430 E 29th St #1005, New York.

  • Where are Quentis Therapeutics offices?

    Quentis Therapeutics has an office in New York.

  • How many offices does Quentis Therapeutics have?

    Quentis Therapeutics has 1 office.